ORIGINAL RESEARCH
Published on 04 Apr 2025
MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study
doi 10.3389/fphar.2025.1465814
- 1,030 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- The Molecular Mechanism in Anti-tumor Therapy Resistance
The Molecular Mechanism in Anti-tumor Therapy Resistance
7,917
Total downloads
29k
Total views and downloads
Articles
CASE REPORT
Published on 10 Mar 2025
Case Report: A novel MET exon 14 skipping mutation after EGFR-TKI resistance in advanced lung adenocarcinoma and sustained clinical response to savolitinib
doi 10.3389/fphar.2025.1489696
- 829 views
REVIEW
Published on 26 Feb 2025
Mitochondria-associated non-coding RNAs and their impact on drug resistance
doi 10.3389/fphar.2025.1472804
- 1,093 views
- 1 citation
CASE REPORT
Published on 20 Feb 2025
Disitamab vedotin combined with pyrotinib as salvage treatment in Her-2-amplified treatment refractory metastatic colorectal cancer: a case report
doi 10.3389/fphar.2025.1431422
- 697 views
REVIEW
Published on 15 Jan 2025
The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs
doi 10.3389/fphar.2024.1437022
- 1,753 views
ORIGINAL RESEARCH
Published on 18 Dec 2024
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
doi 10.3389/fphar.2024.1464852
- 1,603 views
REVIEW
Published on 25 Nov 2024
Long noncoding RNA mediates enzalutamide resistance and transformation in neuroendocrine prostate cancer
doi 10.3389/fonc.2024.1481777
- 1,273 views
REVIEW
Published on 16 Sep 2024
HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
doi 10.3389/fphar.2024.1446414
- 3,633 views
- 4 citations
REVIEW
Published on 06 Sep 2024
Strategies for engineering oncolytic viruses to enhance cancer immunotherapy
doi 10.3389/fphar.2024.1450203
- 1,978 views
- 4 citations
ORIGINAL RESEARCH
Published on 04 Sep 2024
PFKFB3 deprivation attenuates the cisplatin resistance via blocking its autophagic elimination in colorectal cancer cells
doi 10.3389/fphar.2024.1433137
- 1,235 views
- 1 citation
CASE REPORT
Published on 29 Aug 2024
A novel secondary ALK gene mutation which resistant to second-generation TKIs: a case report and literature review
doi 10.3389/fonc.2024.1430350
- 960 views
- 2 citations
REVIEW
Published on 26 Aug 2024
DNA damage response-related ncRNAs as regulators of therapy resistance in cancer
doi 10.3389/fphar.2024.1390300
- 1,547 views
- 3 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore